Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05373173 · ClinicalTrials.gov registry record · NA
Can a Novel Telemedicine Tool Reduce Disparities Related to the Identification of Preschool Children With Autism?
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 148
- Enrollment target
NCT05373173 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 148 participants.
The verdict
NCT05373173, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
Study Summary
Families seeking evaluation for autism spectrum disorder (ASD) often face barriers such as low availability of specialists, lengthy waitlists, and long distances to tertiary care diagnostic centers. This is especially true for children from traditionally underserved groups and communities. Without innovative approaches for enhanced identification of ASD, families and clinicians will continue to struggle with accessing and providing care. Telemedicine offers tremendous potential for addressing this need, but there are few psychometrically sound, validated tools that can be administered remotely, via telehealth platforms. This team of investigators developed and conducted a preliminary evaluation of a novel parent-administered, clinician-guided tele-diagnostic tool, the TAP (TELE-ASD-PEDS), designed specifically for direct-to-home and community clinic use with toddlers. Remote administration of the TAP yielded a very high level of agreement with blinded comprehensive evaluation regarding ASD risk classification. Subsequently, the unanticipated broad dissemination of the TAP during COVID-19 demonstrated its value for traditionally underserved groups, spanning broad geographies. Although promising, this work was limited by its specific focus on toddlers with ASD concerns. A telemedicine tool designed for the unique context and population of preschool-aged children referred for diagnostic assessment could have tremendous value in terms of both accurate identification as well as family engagement with service. In the current work, the investigators will now evaluate the performance, usability, and utility of the TAP-Preschool, a new telemedicine tool for ASD risk assessment in preschoolers, through a clinical trial. The TAP-Preschool was developed through a computationally informed co-production in which the targeted population were recruited as active partners in designing the tool. The investigators will gather critical data not only regarding its structure and accuracy
Interventions
- BEHAVIORAL Tele-assessment only
- BEHAVIORAL Tele-assessment + In-person assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2024-08-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05373173
The ClinicalTrials.gov registry entry for NCT05373173 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tele-assessment only is the first listed.
NCT05373173 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05373173 about?
NCT05373173 is a clinical study titled "Can a Novel Telemedicine Tool Reduce Disparities Related to the Identification of Preschool Children With Autism?". Families seeking evaluation for autism spectrum disorder (ASD) often face barriers such as low availability of specialists, lengthy waitlists, and long distances to tertiary care diagnostic centers. This is especially true for children from traditionally underserved groups and communities. Without i...
What is the current status of trial NCT05373173?
This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2022-06-01. Estimated completion is 2024-08-14.
What interventions are being tested in trial NCT05373173?
The interventions under investigation include: Tele-assessment only (BEHAVIORAL), Tele-assessment + In-person assessment (BEHAVIORAL).
Who is sponsoring clinical trial NCT05373173?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.